READ OUR NEW PRESS RELEASE!!  Announces Positive Top-Line Results FOR HER2DX® in MEDSIR’S PHERGAIN Trial

WORKSHOP
POST-ESMO BREAST CANCER 2023

Learn how HER2DX® can help you apply precision oncology in your clinical practice

ON-DEMAND HERE
HERDX pack photo

Redefining precision oncology

Unlocking the full potential of patient information

We want to change how biomarkers are routinely used in oncology

Separator

Analyze
the Past

Analyzing
complex genomic
and clinical data

Separator

Decode
the present

Decoding biomarkers before,
during or after therapies
using different biopsy-based approaches

Separator

Reveal
the future

Revealing innovative tests of
high analytical complexity,
but easy-to-interpret results

Treatment optimization

THE FIRST GENOMIC TOOL FOR PATIENTS WITH HER2+ BREAST CANCER
PRECISION ON THE DECISIONS

HERDX pack photo